Cardiovascular Medicine Department, Cardiology Center, First Hospital of Jilin University, No.1 Xinmin Street, Changchun City, 130021, Jilin Province, China.
BMC Cardiovasc Disord. 2024 Nov 20;24(1):659. doi: 10.1186/s12872-024-04335-7.
Sex is a determinant of the incidence and etiology of arrhythmia. Observational and basic studies suggest that sex hormones are essential in this process; however, the relationship between sex hormones and arrhythmia remains unclear. Mendelian randomization (MR) was used to investigate the causal relationships between sex hormone levels, arrhythmia, and electrocardiographic (ECG) indices.
Large genome-wide association studies (GWAS) data on sex hormones, stratified by sex, from the UK biobank consortium, were used as exposure data, and data on atrial fibrillation (AF), atrioventricular block, sick sinus syndrome, paroxysmal tachycardia, and ECG indices were obtained from the FinnGen consortium and summarized large GWAS data. Inverse variance weighting or wald odds was used as the primary analytical method, and weighted medians and MR-Egger regression were used for complementary analyses. The results of the MR of sex hormones and AF from different sources were analyzed using a meta-analysis. Summary-data-based MR analysis was utilized to explore the relationship between sex-hormone related drugs and arrhythmia.
In men, genetically predicted higher estradiol concentrations were associated with a lower risk of AF (odds ratio: 0.908 [0.852-0.967]; p = 0.0029], whereas genetically predicted higher concentrations of total testosterone were associated with lower heart rate variability. Sex hormones showed no association with atrioventricular block, sick sinus syndrome, paroxysmal tachycardia, resting heart rate, P wave duration, P wave terminal force in lead V1 [PTFV1], PR interval, QRS duration, QTc [QT interval corrected by heart rate], ST duration, spatial [spQRSTa] and frontal [fQRSTa] QRS-T angles in males. In females, there was no significant evidence that sex hormones are associated with arrhythmias or ECG indices.
In this study, we identified a potential causal relationship between estradiol and the risk of AF in males. However, there was no significant association between sex hormones and either arrhythmias or ECG indices in females. These results suggested that sex hormones may play a limited role in cardiac arrhythmias, which requires further verification.
性别是心律失常发生率和病因的决定因素。观察性和基础研究表明,性激素在这一过程中是必不可少的;然而,性激素与心律失常之间的关系仍不清楚。孟德尔随机化(MR)被用于研究性激素水平、心律失常和心电图(ECG)指标之间的因果关系。
使用英国生物库联盟按性别分层的大型全基因组关联研究(GWAS)性激素数据作为暴露数据,并从芬兰基因联盟获得心房颤动(AF)、房室传导阻滞、窦房结疾病、阵发性心动过速和 ECG 指数的数据,并对大型 GWAS 数据进行了总结。反方差加权或 Wald 优势比被用作主要分析方法,加权中位数和 MR-Egger 回归被用作补充分析。来自不同来源的性激素与 AF 的 MR 结果通过荟萃分析进行了分析。基于汇总数据的 MR 分析用于探索与性激素相关的药物与心律失常之间的关系。
在男性中,遗传预测的较高雌二醇浓度与 AF 的风险降低相关(优势比:0.908 [0.852-0.967];p=0.0029),而遗传预测的较高总睾酮浓度与心率变异性降低相关。性激素与房室传导阻滞、窦房结疾病、阵发性心动过速、静息心率、P 波时限、V1 导联 P 波终末电势[PTFV1]、PR 间期、QRS 时限、QTc[心率校正的 QT 间期]、ST 段、空间[spQRSTa]和额面[fQRSTa]QRS-T 角在男性中均无关联。在女性中,没有证据表明性激素与心律失常或 ECG 指标有显著关联。
在这项研究中,我们确定了雌激素与男性 AF 风险之间存在潜在的因果关系。然而,在女性中,性激素与心律失常或 ECG 指标之间没有显著关联。这些结果表明,性激素在心脏性心律失常中可能起有限作用,这需要进一步验证。